Redmile Group, LLC Sage Therapeutics, Inc. Transaction History

Redmile Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $228,882 - $265,480	-1,450 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $133,995 - $245,475	-1,500 Reduced 50.85%	1,450 $231,000
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $63,913 - $108,973	780 Added 35.94%	2,950 $283,000
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $304,581 - $381,399	2,170 New	2,170 $340,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.